News
Global Cannabis News & Analysis | Business of Cannabis
News · page 18
- Patient Access
Seven Years for Progress, Four Days to Undermine It: The UK’s Cannabis Media Storm
On 6 January 2026, the National Police Chiefs’ Council (NPCC) approved the first official guidance on medical cannabis for officers in England and Wales, news that UK patients have been waiting since 2018 to receive.
- International Regulation
France’s First Prescriptions ‘Unlikely This Year’ Despite ‘Complete’ Framework
Last week, France’s now five-year old medical cannabis pilot programme was extended once again, providing a bridge beyond March 2026 for patients to continue secure access to their medication.
- CBD Market
UK CBD Approvals Face Autumn 2026 Crunch as Industry Proposes Framework Overhaul
The UK’s first-ever CBD product authorisations, originally expected to be completed by Autumn 2026, could now face another setback as Food Standards Scotland (FSS) insists on holding its own consultation.
- Medical Cannabis
France Extends Medical Cannabis Access Again as Full Access Bill Remains Stuck in Limbo
Thousands of French medical cannabis patients will continue to receive their treatment for the foreseeable future, as the highly anticipated full generalised framework edges towards reality.
- International Regulation
Relm and Prohibition Partners Launch Cannabis Risk Briefing for Emerging and High-Growth Industries
Relm Insurance (Relm), the leading insurer focused on emerging industries, today released its Risk Briefing: Cannabis 2026, an inaugural global report produced in collaboration with Prohibition Partners, the industry-first discovery platform for B2B cannabis.
- UK & Europe
The Battle for Germany’s Medical Cannabis Market: Who’s Fighting for What
Today, (Wednesday, January 14), a public hearing will bring together 22 hand-picked experts for a debate on the future country’s near-billion-euro medical cannabis industry.
- US & Canada
Republican Lawmakers Openly Defy Trump on Cannabis Rescheduling
As the excitement around President Donald Trump’s executive order to push forward with cannabis rescheduling has faded, the bill is now facing a much harsher reality.
- Clinical Research
SOMAÍ and Universidade Lusófona Publish Peer-Reviewed Study Validating Full-Spectrum Oil Consistency
SOMAÍ, a leading EU-GMP-certified vertically integrated Multi-Country Operator (MCO) specialising in cannabinoid-based medicines, together with Universidade Lusófona, has published their 4th peer-reviewed study titled “Genotype and chemotype insights of high-THC medicinal Cannabis sativa L.: the role of SSR markers in the identification of cultivars” in the Journal of Cannabis Research.
- Medical Cannabis
Spanish Pharmacists Appeal Hospital-Only Cannabis Rule as Key Regulatory Deadline Passes Unmet
Spain represents one of the most exciting incoming additions to the European medical cannabis market this year, as one of the continent’s largest producers finally moves toward domestic patient access after years of hard-fought advocacy.
- Industry Trends
Inside the Medical Cannabis Police Guidance: Cancards, Driving, and What Patients Need to Know
Earlier this week, the first official guidance on medical cannabis for police officers in England and Wales was made public.
- Medical Cannabis
UK Police Finally Get Official Medical Cannabis Guidance More Than 7 Years After Legalisation
Over seven years after medical cannabis was legalised in the UK, the National Police Chiefs’ Council has approved the first official guidance for medical cannabis.
- International Regulation
Germany’s Medical Cannabis Bill Faces Critical Test as Experts Warn of ‘Unenforceable’ Framework
As Trump’s rescheduling executive order dominated the cannabis industry’s attention over the holiday period, Germany’s controversial medical cannabis bill quietly entered its most critical phase.
